Treatment of CD33-directed Chimeric Antigen Receptor-modified T Cells in One Patient With Relapsed and Refractory Acute Myeloid Leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment of CD33-directed Chimeric Antigen Receptor-modified T Cells in One Patient With Relapsed and Refractory Acute Myeloid Leukemia

Published:2015-01 Issue:1 Volume:23 Page:184-191
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Wang Quan-shun,Wang Yao,Lv Hai-yan,Han Qing-wang,Fan Hui,Guo Bo,Wang Li-li,Han Wei-dong

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference34 articles.

1. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet;Döhner;Blood,2010

2. Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel;Creutzig;Blood,2012

3. Acute myeloid leukemia and novel biological treatments: monoclonal antibodies and cell-based gene-modified immune effectors;Tettamanti;Immunol Lett,2013

4. AML engraftment in the NOD/SCID assay reflects the outcome of AML: implications for our understanding of the heterogeneity of AML;Pearce;Blood,2006

5. Cell surface antigen expression in human erythroid progenitors: erythroid and megakaryocytic markers;Nakahata;Leuk Lymphoma,1994

Cited by 329 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myeloid-derived suppressor cells: Implication in myeloid malignancies and immunotherapy;Acta Histochemica;2024-10

2. Efficient Capture and Traceless Release of Functional CD8⁺ T Cells with a Microfluidic Chip for Enhanced In Vitro and In Vivo CD4-CAR Transduction;Analytical Chemistry;2024-09-13

3. Targeting the membrane-proximal C2-set domain of CD33 for improved CAR T cell therapy;Molecular Therapy: Oncology;2024-09

4. Immune‐dysregulation harnessing in myeloid neoplasms;Cancer Medicine;2024-09

5. Glutamine and leukemia research: progress and clinical prospects;Discover Oncology;2024-08-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3